Nishadil
Ads Astrology Calendar Devs Domains Finance Pay Rewards Weather
Signup Signin
Washington | 15°C (overcast clouds)
Topic Feed

Tyk2Inhibitor

Showing the latest stories and updates for this topic.
Takeda's Zasocitinib Shows Promising Phase III Results for Psoriasis, Signaling a Potential Breakthrough

Takeda's Zasocitinib Shows Promising Phase III Results for Psoriasis, Signaling a Potential Breakthrough
A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval

A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval
Load more..